Shanghai MicroPort EV MedTech Co. Ltd. A Total Liabilities
Shanghai MicroPort EV MedTech Co. Ltd. A total liabilities. Based on the latest financial reports, Shanghai MicroPort EV MedTech Co. Ltd. A (688351) has total liabilities worth CN¥191.14 Million CNY (≈ $27.97 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Shanghai MicroPort EV MedTech Co. Ltd. A asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Shanghai MicroPort EV MedTech Co. Ltd. A (2020–2025)
Total liabilities of Shanghai MicroPort EV MedTech Co. Ltd. A from 2020 to 2025. This chart illustrates how Shanghai MicroPort EV MedTech Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data.
Shanghai MicroPort EV MedTech Co. Ltd. A Competitors by Total Liabilities
The table below lists competitors of Shanghai MicroPort EV MedTech Co. Ltd. A ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nexus AG
F:NXU
|
Germany | €180.79 Million |
|
Olo Inc
NYSE:OLO
|
USA | $71.68 Million |
|
Dynagreen Environmental Protection Group Co Ltd
SHG:601330
|
China | CN¥13.36 Billion |
|
Cansino Biologics Inc
SHG:688185
|
China | CN¥-4.93 Billion |
|
Dowlais Group Plc
LSE:DWL
|
UK | £3.37 Billion |
|
Hammond Power Solutions Inc
TO:HPS-A
|
Canada | CA$294.77 Million |
|
Mitra Adiperkasa Tbk
JK:MAPI
|
Indonesia | Rp14.63 Trillion |
|
Inhibrx Biosciences, Inc.
NASDAQ:INBX
|
USA | $205.00 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down Shanghai MicroPort EV MedTech Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 688351 current and non-current assets.
Liquidity & Leverage Metrics
Shanghai MicroPort EV MedTech Co. Ltd. A Total Liabilities Ratios Explained
Shanghai MicroPort EV MedTech Co. Ltd. A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shanghai MicroPort EV MedTech Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shanghai MicroPort EV MedTech Co. Ltd. A (2020–2025)
The table below shows the annual total liabilities of Shanghai MicroPort EV MedTech Co. Ltd. A from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥190.96 Million ≈ $27.94 Million |
+25.68% |
| 2024-12-31 | CN¥151.95 Million ≈ $22.23 Million |
+9.94% |
| 2023-12-31 | CN¥138.21 Million ≈ $20.22 Million |
+18.28% |
| 2022-12-31 | CN¥116.85 Million ≈ $17.10 Million |
+47.52% |
| 2021-12-31 | CN¥79.21 Million ≈ $11.59 Million |
+16.96% |
| 2020-12-31 | CN¥67.73 Million ≈ $9.91 Million |
-- |
About Shanghai MicroPort EV MedTech Co. Ltd. A
Shanghai MicroPort EP MedTech Co., Ltd. engages in the research, development, production, and sale of medical devices in the field of electrophysiological interventional diagnosis and ablation therapy in China and internationally. The company offers cardiac ablation catheters, diagnostic catheters, and system navigational solutions; access conventional solutions; cryoablation solutions; and robot… Read more